Faculty

Thomas H. Leung, M.D., Ph.D.

Assistant Professor of Dermatology

Department: Dermatology

Graduate Group Affiliations

Contact information

421 Curie Boulevard
1001 Biomedical Research Building II/III, Room 1006
Philadelphia, PA 19104

Email:
thl@pennmedicine.upenn.edu

Education:
B.S. (Biological Sciences)
Stanford University, Stanford, CA, 1998.
Ph.D. (Biology)
California Institute of Technology, Pasadena, CA, 2005.
M.D. (Medicine)
UCLA School of Medicine, Los Angeles, CA, 2007.

Links
Thomas Leung Lab

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Wei J.J., Kim H.S., Spencer C.A., Brennan-Crispi D., Zheng Y., Johnson N.M., Rosenbach M., Miller C., Leung, D.H., Cotsarelis G., and Leung T.H. : Activation of TRPA1 Nociceptor Promotes Systemic Adult Mammalian Skin Regeneration. Science Immunology 5(50), 2020.

Wei J.J., Hayward E.M., Leung T.H., Rosenbach M.: Unbearable wearables. Dermatol Online J 25(12), 2019.

Wei J.J., Kallenbach L.R., Kreider M., Leung T.H., and Rosenbach M. : Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera. JAAD Case Reports 5(4): 360-361, 2019.

Nishiguchi M.A., Spencer C.A., Leung D.H., and Leung T.H. : Aging suppresses skin-derived circulating SDF1 to promote full-thickness tissue regeneration. Cell Reports 24(13): 3383-3392, Oct 2018.

Siprashvili Z, Nguyen NT, Gorell ES, Loutit K, Khuu P, Furukawa LK, Lorenz HP, Leung TH, Keene DR, Rieger KE, Khavari P, Lane AT, Tang JY, Marinkovich MP: Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA 316(17): 1808, 2016.

Leung TH, Snyder ER, Liu Y, Wang J, Kim SK: A cellular, molecular, and pharmacological basis for appendage regeneration in mice. Genes Dev 29(20): 2097-107, 2015.

Gorrell, E.S., Leung, T.H., Khuu, P., Lane, A.T.: Purified Type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol 32(2): 220-5, 2014.

Sebastiano, V., Zhen, H.H., Derafshi, B.H., Bashkirova, E., Melo, S., Wang, P., Leung, T.L., Siprashvili, Z., Tichy, A., Li, J., Ameen, M., Hawkins, J., Lee, S., Li, L., Schwertschkow, A., Bauer, G., Lisowski, L., Kay, M.A., Kim, S.K., Lane, A.T., Wernig, M., Oro, A.E.: Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Science Translational Medicine 26;6(264):264ra163, 2014.

Danial, C., Tichy, A.L., Tariq, U., Swetman, G.L., Khuu, P., Leung, T.H., Benjamin, L., Teng, J, Vasanawala, S.S., Lane, A.T.: An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol S0190-9622(14)01119-0, 2014.

Leung, T.H., Zhang, L.F., Wang, J., Ning, S., Knox, S.J., Kim, S.K. : Topical hypochlorite ameliorates NF-κB-mediated skin diseases in mice. The Journal of Clinical Investigation 123(12): 5361-70, 2013.